Lubeluzole
Lubeluzole is a pharmacological agent that was initially developed for the treatment of stroke and neurodegenerative diseases. It is a neuroprotective drug that works by modulating the glutamate-mediated neurotransmission.
History[edit]
Lubeluzole was first synthesized in the late 20th century as a potential treatment for acute ischemic stroke. It was developed by the Janssen Pharmaceutica, a pharmaceutical company based in Belgium. Despite promising results in early clinical trials, further studies did not confirm its efficacy, and its development was discontinued.
Mechanism of Action[edit]
Lubeluzole's mechanism of action is not fully understood. It is believed to inhibit the release of glutamate, a neurotransmitter that, in excess, can cause neuronal damage. Lubeluzole may also inhibit nitric oxide synthase, an enzyme involved in the production of nitric oxide, a molecule that can cause neuronal damage when produced in excess.
Clinical Trials[edit]
Several clinical trials have been conducted to evaluate the efficacy of lubeluzole in the treatment of acute ischemic stroke. Early trials showed promising results, with patients receiving lubeluzole showing improved outcomes compared to those receiving a placebo. However, later trials did not confirm these results, and the development of lubeluzole for this indication was discontinued.
Current Research[edit]
While lubeluzole is not currently approved for any use, research into its potential applications continues. Some studies suggest that it may have potential as a treatment for neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, but further research is needed to confirm these findings.
See Also[edit]
- Neuroprotection
- Glutamate (neurotransmitter)
- Nitric oxide synthase
- Janssen Pharmaceutica
- Clinical trial
Ad. Transform your life with W8MD's Budget GLP-1 injections from $29.99


W8MD offers medical weight loss programs including NYC medical weight loss and Philadelphia medical weight loss offering:
- Affordable GLP1 shots (generic and brand names) such as
- Wegovy NYC (Semaglutide)
- Zepbound NYC /
- Learn more: Budget GLP1 weight loss injections NYC & Philadelphia GLP1 weight loss shots
- Most insurances accepted
- Lowest cost GLP1 weight loss NYC such as Semaglutide starting from $29.99/week and $45.00/week (Tirzepatide) with insurance.
- Prescription weight loss NYC including:
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your physician weight loss journey today at our:
- NYC medical weight loss
- Philadelphia medical weight loss
- Call 718-946-5500 for NYC or 215-676-2334 for Philadelphia
Tags: Budget glp1 weight loss NYC, Zepbound NYC, Philadelphia medical weight loss, Wegovy NYC, Affordable glp1 shots Philadelphia
Linkedin_Shiny_Icon
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
